Backs FY26 adjusted EBITDA view $165M-$175M. Backs FY25 capital expenditures $50M. The company said, “The Company is reaffirming its full-year outlook for fiscal year 2026. Revenue is anticipated to be in the range of $820 million to $840 million and Adjusted EBITDA is expected to be in the range of $165 million to $175 million. Capital expenditures are expected to total approximately $50 million.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
- Neogen reports Q1 adjusted EPS 4c, consensus 4c
- Options Volatility and Implied Earnings Moves Today, October 09, 2025
- NEOG Earnings this Week: How Will it Perform?
- Options Volatility and Implied Earnings Moves This Week, October 06 – October 09, 2025
- Neogen initiated with a Market Perform at CJS Securities